Search for a trial

A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and
Safety of CNTO 328 (Anti-IL-6 Monoclonal Antibody) Plus Best Supportive Care
Compared With Best Supportive Care in Subjects With Multicentric Castleman*s
Disease

Primary Objective:The primary objective of this study is to demonstrate that CNTO 328 in combination with BSC is superiorto BSC in terms of objective response (complete response [CR] + partial response [PR]) among subjectswith multicentric Castleman…

LYMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial.

To assess the impact of access to feedback and access to an internet-based self-management intervention after primary treatment of lymphoma by increasing self-management and decreasing distress. We hypothesise that patients who have access to…

Cardiomyopathy and heart failure risk after treatment for Hodgkin lymphoma or aggressive B cell non-Hodgkin lymphoma

To assess risk factors for cardiomyopathy and heart failure among lymphoma (HL and aggressive B-cell NHL) survivors, focusing on the independent and joint effects of doses of anthracycline-containing chemotherapy (doxorubicin) and rituximab as well…